The market for bioceramics and hydroxyapatite market is anticipated to continue to grow at a 6.9% CAGR over the course of the forecast period, with a strong long-term outlook (2022-2028). The aluminium oxide segment is anticipated to maintain its dominance and represent approximately 45% of the worldwide bioceramics and hydroxyapatite market. Due to improved characteristics including high mechanical strength and biocompatibility, hydroxyapatite, a bio-inert ceramic with these qualities, will continue to be a favoured component in the manufacturing of orthopaedic implants. Zirconia-based bioceramics are also widely utilised for dental implants, and it is anticipated that they will continue to represent a lucrative market niche in the overall bioceramics and hydroxyapatite market.
Healthcare organizations like to invest in hydroxyapatite since it interacts with the body’s living tissues to provide efficient solutions for bone formation. The scope of market growth for the worldwide bioceramics and hydroxyapatite market has been expanded due to the increasing use of hydroxyapatite in the healthcare sector. In 2017, the market for hydroxyapatite and bioceramics saw a year-over-year growth of 5.7%. The global market for bioceramics and hydroxyapatite is anticipated to reach US$ 3 billion by the end of 2022. By the end of 2018, North America and Europe are expected to hold a value share of roughly 60% of the global market for bioceramics and hydroxyapatite, and it is predicted that demand for these materials will grow moderately due to their use in dental and orthopaedic implants as well as other applications.
For insights on global, regional, and country-level parameters with growth opportunities from 2022 to 2028 – Download a sample report: https://www.futuremarketinsights.com/reports/sample/rep-gb-7049
Bioceramics are also known as medical ceramics as they are mainly used as an important component in the production of the dental and orthopedic implants. Bioceramics materials are mostly oxides, carbides or nitrides based. Preference for bioceramics continues to persist and they can be distinguished as biologically active, inert or resorbable depending on the material type. Aluminum oxide, zirconia, calcium phosphate (tricalcium phosphate, hydroxyapatite) and bioglass are witnessed to be some of the commonly used bioceramics across industries. Hydroxyapatite is a calcium phosphate bioceramic and is biologically active by nature. The natural human bone comprises 70% hydroxyapatite. Thus it has excellent biocompatibility. Hydroxyapatite also aids in the bone growth and promotes bone health. However, low mechanical strength of hydroxyapatite has constrained the application of hydroxyapatite to coat the metal implants to trick the body as the tissues will directly come in contact of bioceramics and hydroxyapatite instead of metal. Thus the implants can gain the strength of the metal and biological acceptability of bioceramics and hydroxyapatite.
Growing need for developing effective dental implants, hip, joints, and knee replacement devices are projected to fuel demand for bioceramics and hydroxyapatite over the forecast period. Production of implants per capita has further translated to an exponential market growth over the past decade.
There has been increase in percentage of ageing population which are prone to greater risk of diseases such as osteoarthritis, knee , joint and hip problems, tooth decay amongst others. Ageing population coupled with other factors such as increasing number of accidents, bad eating habits leading to tooth decay amongst others is projected to drive the demand for bioceramics and hydroxyapatite over the forecast period.
Attributed to enhanced biocompatibility, high mechanical strength, and chemical and thermal stability, bioceramics and hydroxyapatite are increasingly being used for orthopaedic and dental implants. Growing health concerns pertaining to the impact of the materials used for developing dental implants has led manufacturers to direct their investments towards utilizing titanium as an important component. However, lack of maintenance of titanium implants can result in corrosion of the implants. To offer improved patient care, the manufacturers are developing zirconia-based implants that are white colored ceramic material. These implants offer improved biocompatibility and are likely to encourage demand for bioceramics and hydroxyapatite in the healthcare industry.
Contrary to the factors boosting the market growth, availability of bioceramics and hydroxyapatite at premium prices and lack of awareness among consumers is likely to inhibit growth of the global bioceramics and hydroxyapatite market over the coming years. Also, lack of technological advancements in developing countries of Asia Pacific region there has been still been prevalence of metal-based implants which may hinder the bioceramics and hydroxyapatite market growth in the long run.
To remain in the forefront of the competitive market, leading market players are focusing on long-term partnerships with implant manufacturers, and expanding their regional footprints in the bioceramics and hydroxyapatite market. In-depth research and development have also been conducted for developing 3-D printing and artificial bones thus expanding the application area and product offerings for bioceramics and hydroxyapatite.
Segmentation Analysis
- On the basis of material type, the aluminium oxide segment is projected to retain its dominance in the global bioceramics and hydroxyapatite market throughout the forecast period, accounting for a value share of ~45% by the end 2018.
- On the basis of type, bio-inert is expected to remain a leading segment in the global bioceramics and hydroxyapatite market, recording a CAGR of 6.8% over the forecast period. However, the bio-active segment is expected to witness higher growth rate in terms of value.
- On the basis of application, sales of the bioceramics and hydroxyapatite is likely to remain concentrated for the development of the orthopaedic implants. However, other applications such as dental implants and implantable electronic devices are projected to witness significant growth over the coming years in terms of consumption.
Vendor Insights
The report highlights some of the top companies operating in the global bioceramics and hydroxyapatite market, which include Morgan Technical Ceramics, CeramTec, Berkeley Advanced Biomaterials, Inc., Kyocera Corporation, Cam Bio Ceramics BV, FLUIDINOVA, Premier Biomaterials, Plasma Biotal Ltd., SofSera, Bonesupport AB, Nano Interface Technology, and Sigma Graft amongst others.
Expand operations in the future – To get requisite details, ask for a custom report: https://www.futuremarketinsights.com/customization-available/rep-gb-7049
Global Bioceramics and Hydroxyapatite Market Segmentation
To understand and assess opportunities in the global bioceramics and hydroxyapatite Market, we have divided the report into three sections based on market segmentation as under:
By Material Type
- Aluminium Oxide
- Zirconia
- Calcium Phosphate
- Others
By Type
- Bio-Inert
- Bio-Active
- Bio-Resorbable
By Application
- Dental Implants
- Orthopaedic Implants
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
